What to Make of Agenus Stock (NASDAQ:AGEN) Post Reverse Stock Split

Clinical-stage immuno-oncology company Agenus (NASDAQ:AGEN) recently executed a 1-for-20 reverse stock split to give the company greater flexibilit...#agenus
Source: Reuters: Health - Category: Consumer Health News Source Type: news